Inhibition of K-ras-transformed rodent and human cancer cell growth via induction of apoptosis by irreversible inhibitors of ras endoprotease

Cancer Letters

Volumn 131, Issue 2, 1998, Pages 191-200

  Chen, Yulong ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Apoptosis; Cancer cells; Cell growth; Endoprotease; Inhibitors; Ras

Indexed keywords

KETONE DERIVATIVE; PROTEINASE INHIBITOR; UM 96001; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT;

3T3 CELLS; AMINO ACID CHLOROMETHYL KETONES; ANIMALS; APOPTOSIS; CELL DIVISION; CELL LINE, TRANSFORMED; ENZYME INHIBITORS; GENES, RAS; HUMANS; MICE; PALMITIC ACIDS; RAS PROTEINS; RATS;

RODENTIA;

EID: 0031756961     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00146-3     Document Type: Article

References (44)

1. Bos J.L. ras oncogenes in human cancer: a review. Cancer Res. 49:1989;4682-4689.
2. Lowy D.R., Willumsen B.M. Function and regulation of Ras. Annu. Rev. Biochem. 62:1993;851-891.
3. Barbacid M. ras genes. Annu. Rev. Biochem. 56:1987;779-827.
4. Gelb M.H. Protein prenylation, et cetera: signal transduction in two dimensions. Science. 275:1997;1750-1751.
5. S. Clarke, Protein isoprenylation and methylation at carboxyl-terminal cysteine residues, Annu. Rev. Biochem. 61 (1992) 355-386; P.J. Casey, Protein lipidation in cell signaling, Science 268 (1995) 221-225; A. Hall, Rho GTPases and the actin cytoskeleton, Science 279 (1998) 509-514; R.B. Lobell, Prenylation of Ras GTPase superfamily proteins and their function in immunology, Adv. Immunol. 68 (1998) 145-189.
6. S. Clarke, Protein isoprenylation and methylation at carboxyl-terminal cysteine residues, Annu. Rev. Biochem. 61 (1992) 355-386; P.J. Casey, Protein lipidation in cell signaling, Science 268 (1995) 221-225; A. Hall, Rho GTPases and the actin cytoskeleton, Science 279 (1998) 509-514; R.B. Lobell, Prenylation of Ras GTPase superfamily proteins and their function in immunology, Adv. Immunol. 68 (1998) 145-189.
7. S. Clarke, Protein isoprenylation and methylation at carboxyl-terminal cysteine residues, Annu. Rev. Biochem. 61 (1992) 355-386; P.J. Casey, Protein lipidation in cell signaling, Science 268 (1995) 221-225; A. Hall, Rho GTPases and the actin cytoskeleton, Science 279 (1998) 509-514; R.B. Lobell, Prenylation of Ras GTPase superfamily proteins and their function in immunology, Adv. Immunol. 68 (1998) 145-189.
8. S. Clarke, Protein isoprenylation and methylation at carboxyl-terminal cysteine residues, Annu. Rev. Biochem. 61 (1992) 355-386; P.J. Casey, Protein lipidation in cell signaling, Science 268 (1995) 221-225; A. Hall, Rho GTPases and the actin cytoskeleton, Science 279 (1998) 509-514; R.B. Lobell, Prenylation of Ras GTPase superfamily proteins and their function in immunology, Adv. Immunol. 68 (1998) 145-189.
9. K.S. Koblan, N.E. Kohl, C.A. Omer, N.J. Anthony, M.W. Conner, S.J. deSolms, T.M. Williams, S.L. Graham, G.D. Hartman, A. Oliff, J.B. Gibbs, Farnesyltransferase inhibitors: a new class of cancer chemotherapeutics, Biochem. Soc. Trans. 24 (1996) 688-692; G.J. Kelloff, R.A. Lubet, J.R. Fay, V.E. Steele, C.W. Boone, J.A. Crowell, C.C. Sigman, Farnesyl protein transferase inhibitors as potential cancer chemopreventives, Cancer Epidemiol. Biomarkers Prev. 6 (4) (1997) 267-282; A.D. Cox, C.J. Der, Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?, Biochim. Biophys. Acta 1333 (1997) F51-F71.
10. K.S. Koblan, N.E. Kohl, C.A. Omer, N.J. Anthony, M.W. Conner, S.J. deSolms, T.M. Williams, S.L. Graham, G.D. Hartman, A. Oliff, J.B. Gibbs, Farnesyltransferase inhibitors: a new class of cancer chemotherapeutics, Biochem. Soc. Trans. 24 (1996) 688-692; G.J. Kelloff, R.A. Lubet, J.R. Fay, V.E. Steele, C.W. Boone, J.A. Crowell, C.C. Sigman, Farnesyl protein transferase inhibitors as potential cancer chemopreventives, Cancer Epidemiol. Biomarkers Prev. 6 (4) (1997) 267-282; A.D. Cox, C.J. Der, Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?, Biochim. Biophys. Acta 1333 (1997) F51-F71.
11. K.S. Koblan, N.E. Kohl, C.A. Omer, N.J. Anthony, M.W. Conner, S.J. deSolms, T.M. Williams, S.L. Graham, G.D. Hartman, A. Oliff, J.B. Gibbs, Farnesyltransferase inhibitors: a new class of cancer chemotherapeutics, Biochem. Soc. Trans. 24 (1996) 688-692; G.J. Kelloff, R.A. Lubet, J.R. Fay, V.E. Steele, C.W. Boone, J.A. Crowell, C.C. Sigman, Farnesyl protein transferase inhibitors as potential cancer chemopreventives, Cancer Epidemiol. Biomarkers Prev. 6 (4) (1997) 267-282; A.D. Cox, C.J. Der, Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?, Biochim. Biophys. Acta 1333 (1997) F51-F71.
12. Kohl N.E., Mosser S.D., deSolms S.J., Giuliani E.A., Pompliano D.L., Graham S.L., Smith R.L., Scolnick E.M., Oliff A., Gibbs J.B. Selective inhibition of Ras-dependent transformation by a farnesyltransferase inhibitor. Science. 260:1993;1934-1937.
13. James G.L., Goldstein J.L., Brown M.S., Rawson T.E., Somers T.C., McDowell R.S., Crowley C.W., Lucas B.K., Levinson A.D., Marsters J.C. Jr. Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells. Science. 260:1993;1937-1942.
14. Garcia A.M., Rowell C., Ackermann K., Kowalczyk J.J., Lewis M.D. Peptidomimetic inhibitors of Ras farnesylation and function in whole cells. J. Biol. Chem. 268:1993;18415-18418.
15. ras farnesyltransferase. J. Biol. Chem. 269:1994;12410-12413.
16. Manne V., Yan N., Carboni J.M., Tuomari A.V., Ricca C.S., Brown J.G., Andahazy M.L., Schmidt R.J., Patel D., Zahler R., Weinmann R., Der C.J., Cox A.D., Hunt J.T., Gordon E.M., Barbacid M., Seizinger B.R. Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells. Oncogene. 10:1995;1763-1779.
17. Kohl N.E., Omer C.A., Conner M.W., Anthony N.J., Davide J.P., deSolms S.J., Giuliani E.A., Gomez R.P., Graham S.L., Hamilton K., Handt L.K., Hartmen G.D., Koblan K.S., Kral A.M., Miller P.J., Mosser S.D., O'Neill T.J., Rands E., Schaber M.D., Gibbs J.B., Oliff A. Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in Ras transgenic mice. Nat. Med. 1:1995;792-797.
18. Kauffmann-Zeh A., Rodriguez-Viciana P., Ulrich E., Gilbert C., Coffer P., Downward J., Evan G. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature. 385:1997;544-548.
19. Lin H.J., Eviner V., Prendergast G.C., White E. Activated H-Ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest. Mol. Cell. Biol. 18:1995;4536-4544.
20. Gardner A.N., Johnson G.L. Fibroblast growth factor-2 suppression of tumor necrosis factor alpha-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase. J. Biol. Chem. 271:1996;14560-14566.
21. Goillot E., Raingeaud J., Ranger A., Tepper R.I., Davis R.J., Harlow E., Sanchez I. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc. Natl. Acad. Sci. USA. 94:1997;3302-3307.
22. Mayo M.W., Wang C.-Y., Cogswell P.C., Rogers-Graham K.S., Lowe S.W., Der C.J., Baldwin A.A. Jr. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science. 278:1997;1812-1815.
23. Yamada-Okabe T., Doi R., Yamada-Okabe H. Normal and transforming Ras are differently regulated for posttranslational modifications. J. Cell. Biochem. 61:1996;172-181.
24. Lebowitz P.F., Sakamuro D., Prendergast G.C. Farnesyl transferase inhibitors induce apoptosis of Ras-transformed cells denied substratum attachment. Cancer Res. 57:1997;708-713.
25. Bernhard E.J., Kao D., Cox A.D., Sebti S.M., Hamilton A.D., Muschel R.J., McKenna W.G. The farnesyltransferase inhibitor FTI-277 radiosensitizes H-ras-transformed rat embryo fibroblasts. Cancer Res. 56:1996;1727-1730.
26. Barrington R.E., Subler M.A., Rands E., Omer C.A., Miller P.J., Hundley J.E., Koester S.K., Troyer D.A., Bearss D.J., Conner M.W., Gibbs J.B., Hamilton K., Koblan K.S., Mosser S.D., O'Neill T.J., Schaber M.D., Senderak E.T., Windle J.J., Oliff A., Kohl N.E. A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis. Mol. Cell. Biol. 18:1998;85-92.
27. Kato K., Cox A.D., Hisaka M.M., Graham S.M., Buss J.E., Der C.J. Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity. Proc. Natl. Acad. Sci. USA. 89:1992;6403-6407.
28. Y. Chen, Selective and irreversible inhibition of Ras protease by tosyl-L-phenylalanine chloromethyl ketone, ASBMB/DBC-ACS Joint Meeting in San Francisco, Late Breaking Abstract LB 46 (Addendum to FASEB J. 9 (6) (1995)).
29. Chen Y., Ma Y.-T., Rando R.R. Solubilization, partial purification, and affinity labeling of the membrane-bound isoprenylated protein endoprotease. Biochemistry. 35:1996;3227-3237.
30. Boyartchuk V.L., Ashby M.N., Rine J. Modulation of Ras and a-factor function by carboxyl-terminal proteolysis. Science. 275:1997;1796-1800.
31. Nishii W., Muramatsu T., Kuchino Y., Yokoyama S., Takahashi K. Partial purification and characterization of a CAAX-motif-specific protease from bovine brain using a novel fluorometric assay. J. Biochem. 122:1997;402-408.
32. K-Ras(B). EMBO J. 10:1991;641-646.
33. M.N. Ashby, D.S. King, J. Rine, Endoproteolytic processing of a farnesylated peptide in vitro, Proc. Natl. Acad. Sci. USA 89 (1992) 4613-4617; Y.-T. Ma, R.R. Rando, A microsomal endoprotease that specifically cleaves isoprenylated peptides, Proc. Natl. Acad. Sci. USA 89 (1992) 6275-6279; G.-F. Jang, K. Yokoyama, M.H. Gelb, A prenylated protein-specific endoprotease in rat liver microsomes that produces carboxyl-terminal tripeptide, Biochemistry 32 (1993) 9500-9507.
34. M.N. Ashby, D.S. King, J. Rine, Endoproteolytic processing of a farnesylated peptide in vitro, Proc. Natl. Acad. Sci. USA 89 (1992) 4613-4617; Y.-T. Ma, R.R. Rando, A microsomal endoprotease that specifically cleaves isoprenylated peptides, Proc. Natl. Acad. Sci. USA 89 (1992) 6275-6279; G.-F. Jang, K. Yokoyama, M.H. Gelb, A prenylated protein-specific endoprotease in rat liver microsomes that produces carboxyl-terminal tripeptide, Biochemistry 32 (1993) 9500-9507.
35. M.N. Ashby, D.S. King, J. Rine, Endoproteolytic processing of a farnesylated peptide in vitro, Proc. Natl. Acad. Sci. USA 89 (1992) 4613-4617; Y.-T. Ma, R.R. Rando, A microsomal endoprotease that specifically cleaves isoprenylated peptides, Proc. Natl. Acad. Sci. USA 89 (1992) 6275-6279; G.-F. Jang, K. Yokoyama, M.H. Gelb, A prenylated protein-specific endoprotease in rat liver microsomes that produces carboxyl-terminal tripeptide, Biochemistry 32 (1993) 9500-9507.
36. K. Hanada, M. Tamai, M. Yamagishi, Isolation and characterization of E-64, a new thiol protease inhibitor, Agric. Biol. Chem. 42 (1978) 523-528; A. Albeck, S. Fluss, R. Persky, Peptidyl epoxides - novel selective inactivators of cysteine proteases, J. Am. Chem. Soc. 118 (1996) 3591-3596.
37. K. Hanada, M. Tamai, M. Yamagishi, Isolation and characterization of E-64, a new thiol protease inhibitor, Agric. Biol. Chem. 42 (1978) 523-528; A. Albeck, S. Fluss, R. Persky, Peptidyl epoxides - novel selective inactivators of cysteine proteases, J. Am. Chem. Soc. 118 (1996) 3591-3596.
38. Enomoto T., Inoue M., Perantoni A.O., Terakawa N., Tanizawa O., Rice J.M. K-ras activation in neoplasms of the human female reproductive tract. Cancer Res. 50:1990;6139-6145.
39. Cryns V.L., Bergeron L., Zhu H., Li H., Yuan J. Specific cleavage of alpha-fodrin during Fas- and tumor necrosis factor-induced apoptosis is mediated by an interleukin-1beta-converting enzyme/Ced-3 protease distinct from the poly(ADP-ribose) polymerase protease. J. Biol. Chem. 271:1996;31277-31282.
40. Zhang F.L., Casey P.J. Protein prenylation: molecular mechanisms and functional consequences. Annu. Rev. Biochem. 65:1996;241-269.
41. V12 proteins to farnesyltransferase inhibitors in Rat1 cells. Proc. Natl. Acad. Sci. USA. 93:1996;4454-4458.
42. Oldham S.M., Clark G.J., Gangarosa L.M., Coffey R.J. Jr., Der C.J. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. Proc. Natl. Acad. Sci. USA. 93:1996;6924-6928.
43. Dudley D.T., Pang L., Decker S.T., Bridges A.J., Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA. 92:1995;7686-7689.
44. Lacal J.C. Regulation of proliferation and apoptosis by Ras and Rho GTPases through specific phospholipid-dependent signaling. FEBS Lett. 410:1997;73-77.